pharma3

Pharma Holdings

Newly appointed investor relations firm

Pharma Holding Incorporated

Advest Capital

More Later

17

This is a direct unedited paste of a press announcement made by Pharma Holding. There are additions by the webmaster.

Should there be any errors, please advise me by e. mail.

Previous Pharma page.

Boiler Rooms Page.

If you have visited this page, please inform the webmaster. Thanks

IMHO

July 1st. 2008

PRESS RELEASE

For Immediate Release:

PHARMA HOLDINGS APPOINTS INVESTOR RELATIONS FIRM ADVEST CAPITAL

July 1, 2008 – Pharma Holdings Incorporated (PHI) has appointed the European-based ADVEST CAPITAL PARTNERS as its investor relations firm.

Advest Capital Partners is one of the premier investment banking and investor relations specialists in Europe and also in the United States. Advest Capital specializes in the small business segment of the market and is well-qualified to represent the needs of PHI, and their shareholders. Advest Capital will provide PHI with expertise relating to public relations, customer service and enable PHI to focus on building shareholder value, while assisting PHI to successfully list our company with one of the major exchanges. These services include the establishment of a valuation model to correctly price Pharma, and assistance with the review and correction process to bring all of our corporate documents to public listing standards.

According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this partnership will enable PHI shareholders to be more involved and informed with the everyday operations of the company. We are enamored with the track-record of Advest Capital and look forward to working with them”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings is specialized in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries.

According to Mr. Klapp, this relationship with Advest Capital provides a one-stop business solution that will enable us to focus on growing the company while having access to financing to make new acquisitions. The relationship with Advest Capital will “foster this growth and expansion to become a reality”, according to Mr. Klapp. Shareholders of PHI may contact Advest Capital through our local UK phone number at 44-1215100377and can be found on the Internet at www.AdvestCapital.com. Advest Capital Partners is a wholly-owned subsidiary of Pharma Holdings Incorporated but operates as a unique business to serve clients in the financial services arena.

The site is also currently promoting Clean Coal Technology.

Website info for Advest Capital

Note the site is only a few months old, yet one page is © 2005!

See link below right.

Domain Name: advestcapital.com

Status: clientTransferProhibited (This is a normal entry)

Registrar: REGISTER.COM, INC.

Whois Server: whois.register.com

Referral URL: http://www.register.com

Expiration Date: 2009-05-28

Creation Date: 2008-05-28

Last Update Date: 2008-05-28

Name Servers:

ns1.flabackbone.com

ns2.flabackbone.com

AdvestCapital © 2005

This is being said of a Regulation S stock!

So you’re looking for the next potential big gainer, right? Because savvy traders are getting rich on China plays – with 300%, 400% and 1000% gains – all within a matter of weeks.

Regulation S Website

Regulation S.net

This site will not accept "U.S. Persons" as members.

Regulation-S.net ™ is a market place and trading platform for securities of U.S. companies that have been issued pursuant to Regulation-S. The two main services provided are a primary marketplace where the investor can choose and purchase newly issued Regulation-S stock directly from a variety of issuers, and a secondary markets for the buying and selling of Regulation-S issues that have already been placed with investors.

Regulation-S stock issues of U.S. companies are freely tradable outside of the united states by everyone except "U.S. Persons" as defined by Regulation-S.

What I wonder is if the "Boilers" are using us to allow "U.S Persons" to trade these stocks by proxy!

Benefits

Companies find three main benefits in using Reg S to raise money:

* they can readily access receptive foreign investors and foreign capital markets;

* the paperwork is relatively simple;

* the process is cheaper and faster than the complexities of a registered offering.

Offshore investors often like Reg S offerings because they usually buy shares at a nice discount that helps compensate for the risk of the 12-month holding period. Later they can sell the stock in the vast, dynamic and liquid U.S. public market.

NB

What this does NOT say is that some Reg S companies have failed to raise cash in other ways and they are seen as more risky. THAT is why they are not available to US citizens!

Page set up July 11th. 22-05 BST.

July 1st. 2008	PRESS RELEASE For Immediate Release: PHARMA HOLDINGS APPOINTS INVESTOR RELATIONS FIRM ADVEST CAPITAL
	July 1, 2008 – Pharma Holdings Incorporated (PHI) has appointed the European-based ADVEST CAPITAL PARTNERS as its investor relations firm.
	Advest Capital Partners is one of the premier investment banking and investor relations specialists in Europe and also in the United States. Advest Capital specializes in the small business segment of the market and is well-qualified to represent the needs of PHI, and their shareholders. Advest Capital will provide PHI with expertise relating to public relations, customer service and enable PHI to focus on building shareholder value, while assisting PHI to successfully list our company with one of the major exchanges. These services include the establishment of a valuation model to correctly price Pharma, and assistance with the review and correction process to bring all of our corporate documents to public listing standards.
	According to Edward Klapp, CEO & President, Pharma Holdings Incorporated, “this partnership will enable PHI shareholders to be more involved and informed with the everyday operations of the company. We are enamored with the track-record of Advest Capital and look forward to working with them”. Currently Pharma Holdings operates three subsidiaries; Canadian Drug Outlet, Med-RX Supply and Med-RX Health. Pharma Holdings is specialized in the sales of wholesale medical supplies and devices and currently has clients in the USA, Canada and several other countries.
	According to Mr. Klapp, this relationship with Advest Capital provides a one-stop business solution that will enable us to focus on growing the company while having access to financing to make new acquisitions. The relationship with Advest Capital will “foster this growth and expansion to become a reality”, according to Mr. Klapp. Shareholders of PHI may contact Advest Capital through our local UK phone number at 44-1215100377and can be found on the Internet at www.AdvestCapital.com. Advest Capital Partners is a wholly-owned subsidiary of Pharma Holdings Incorporated but operates as a unique business to serve clients in the financial services arena. The site is also currently promoting Clean Coal Technology.

Regulation S Website	Regulation S.net
This site will not accept "U.S. Persons" as members.	Regulation-S.net ™ is a market place and trading platform for securities of U.S. companies that have been issued pursuant to Regulation-S. The two main services provided are a primary marketplace where the investor can choose and purchase newly issued Regulation-S stock directly from a variety of issuers, and a secondary markets for the buying and selling of Regulation-S issues that have already been placed with investors. Regulation-S stock issues of U.S. companies are freely tradable outside of the united states by everyone except "U.S. Persons" as defined by Regulation-S.
What I wonder is if the "Boilers" are using us to allow "U.S Persons" to trade these stocks by proxy!	Benefits Companies find three main benefits in using Reg S to raise money: * they can readily access receptive foreign investors and foreign capital markets; * the paperwork is relatively simple; * the process is cheaper and faster than the complexities of a registered offering. Offshore investors often like Reg S offerings because they usually buy shares at a nice discount that helps compensate for the risk of the 12-month holding period. Later they can sell the stock in the vast, dynamic and liquid U.S. public market.
NB	What this does NOT say is that some Reg S companies have failed to raise cash in other ways and they are seen as more risky. THAT is why they are not available to US citizens!